RELMADA THERAPEUTICS, INC. Other Non-Current Assets
RELMADA THERAPEUTICS, INC. (RLMD) had Other Non-Current Assets of $19.50 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-06
- 2026-06-30: Other Assets, Noncurrent $19.50K.
- 2026-03-31: Other Assets, Noncurrent $19.50K.
- 2025-12-31: Other Assets, Noncurrent $19.50K.
- 2025-09-30: Other Assets, Noncurrent $21.98K.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-06-30 | $19.50K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $19.50K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $19.50K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $21.98K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $21.98K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $21.98K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $21.98K 10-K · filed 2026-03-19 |
| 2024-09-30 | $21.98K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $53.63K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $43.13K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $43.13K 10-K · filed 2025-03-27 |
| 2023-09-30 | $47.72K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $34.59K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $34.88K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $34.88K 10-K · filed 2024-03-19 |
| 2022-09-30 | $16.09K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $35.24K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $28.29K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $28.29K 10-K · filed 2023-03-23 |
| 2021-09-30 | $25.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $25.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $25.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $25.00K 10-K · filed 2022-03-25 |
| 2020-09-30 | $25.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $25.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $25.00K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $25.00K 10-K · filed 2021-03-24 |
| 2019-09-30 | $25.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $25.00K 10-K · filed 2021-03-24 |
| 2019-03-31 | $43.91K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $18.91K 10-Q · filed 2019-02-13 |
| 2018-09-30 | $18.91K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $24.79K 10-KT · filed 2020-03-26 |
| 2018-03-31 | $21.60K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $21.96K 10-Q · filed 2018-02-12 |
| 2017-09-30 | $21.96K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $21.96K 10-K · filed 2018-09-28 |
| 2017-03-31 | $415.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $414.81K 10-Q · filed 2017-02-10 |
| 2016-09-30 | $414.62K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $414.36K 10-K · filed 2017-09-28 |
| 2016-03-31 | $412.79K 10-Q · filed 2016-05-09 |
| 2015-06-30 | $400.82K 10-K · filed 2016-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |